Susan G. Komen for the Cure® Announces CEO Resignation

DALLAS - November 19, 2009 - The Board of Susan G. Komen for the Cure®, the world’s largest breast cancer organization, today announced the resignation of Hala Moddelmog as President and CEO.

Moddelmog has served the organization since 2006. During her tenure, the organization experienced a time of significant growth and expansion, including the establishment of Susan G. Komen for the Cure’s Scientific Advisory Board, the organization’s largest annual investment in research, the founding of the Susan G. Komen for the Cure Advocacy Alliance and strong international expansion, including establishment of the Susan G. Komen for the Cure Global Promise Fund.

“Hala deserves tremendous praise for the work she has done in elevating the organization and the cause, especially the strengthening of our Affiliate grassroots efforts – the backbone of Susan G. Komen for the Cure,” said Alexine Clement Jackson, chairperson of Susan G. Komen for the Cure’s board of directors. “The organization is incredibly strong financially and operationally and is poised for tremendous growth.”

"As a breast cancer survivor myself, I have said since the day I joined Komen that I consider this job as a gift...to give back to the breast cancer movement that has saved so many lives," said Hala Moddelmog. "I feel the same today and remain committed to doing all I can to help end breast cancer forever.”

Moving forward, Susan G. Komen for the Cure Founder, Ambassador Nancy G. Brinker, will take on an even more active leadership role in collaboration with the board of directors and the organization’s senior leadership. Brinker’s involvement is key as the organization continues its aggressive global growth, broadens advocacy efforts and continues to strengthen the grassroots base.     

“Susan G. Komen for the Cure is fortunate to have a founder who is still actively engaged in the heart of the organization in a volunteer capacity,” Jackson continued. “Nancy Brinker’s continued vision and leadership, especially in global and diplomatic matters, is key as we tackle the global breast cancer crisis.”

The organization has not announced plans for Moddelmog’s long-term replacement.